↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Monteiro R) "

Search: WFRF:(Monteiro R)

Result 1-10 of 122

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Jakobsson, J., et al. (author) Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 2021 In: Autophagy. - : Informa UK Limited. - 1554-8635 .- 1554-8627. ; 17:1, s. 1-382 Journal article (peer-reviewed)
2.	Roe, MT, et al. (author) Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes 2019 In: Circulation. - : Ovid Technologies (Wolters Kluwer Health). - 1524-4539 .- 0009-7322. ; 140:19, s. 1578-1589 Journal article (peer-reviewed)
3.	Jukema, JW, et al. (author) Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1167-1176 Journal article (peer-reviewed)
4.	Ray, KK, et al. (author) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 2019 In: The lancet. Diabetes & endocrinology. - 2213-8595 .- 2213-8587. ; 7:8, s. 618-628 Journal article (peer-reviewed)
5.	Szarek, M, et al. (author) Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial 2019 In: Circulation. Cardiovascular quality and outcomes. - : Ovid Technologies (Wolters Kluwer Health). - 1941-7705 .- 1941-7713. ; 12:11, s. e005858- Journal article (peer-reviewed)
6.	Szarek, M, et al. (author) Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 73:4, s. 387-396 Journal article (peer-reviewed)
7.	Bittner, VA, et al. (author) Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome 2020 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 75:2, s. 133-144 Journal article (peer-reviewed)
8.	Goodman, SG, et al. (author) Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1177-1186 Journal article (peer-reviewed)
9.	Schwartz, GG, et al. (author) Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome 2018 In: The New England journal of medicine. - : MASSACHUSETTS MEDICAL SOC. - 1533-4406 .- 0028-4793. ; 379:22, s. 2097-2107 Journal article (peer-reviewed)
10.	Acharya, B. S., et al. (author) Introducing the CTA concept 2013 In: Astroparticle physics. - : Elsevier BV. - 0927-6505 .- 1873-2852. ; 43, s. 3-18 Journal article (other academic/artistic)abstract The Cherenkov Telescope Array (CTA) is a new observatory for very high-energy (VHE) gamma rays. CTA has ambitions science goals, for which it is necessary to achieve full-sky coverage, to improve the sensitivity by about an order of magnitude, to span about four decades of energy, from a few tens of GeV to above 100 TeV with enhanced angular and energy resolutions over existing VHE gamma-ray observatories. An international collaboration has formed with more than 1000 members from 27 countries in Europe, Asia, Africa and North and South America. In 2010 the CTA Consortium completed a Design Study and started a three-year Preparatory Phase which leads to production readiness of CTA in 2014. In this paper we introduce the science goals and the concept of CTA, and provide an overview of the project. (C) 2013 Elsevier B.V. All rights reserved.

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 122

Refine your search

Type of publication: journal article (99); conference paper (19); research review (3); book (1)

Type of content: peer-reviewed (109); other academic/artistic (13)

Author/Editor: Chenevix-Trench, G (15); Sousa, L (14); Anton-Culver, H (13); Fasching, PA (13); Lambrechts, D (13); Chang-Claude, J (13); show more...; Nevanlinna, H (13); Tischkowitz, M (13); Butzow, R (12); Zheng, W. (12); Dennis, J (12); Giles, GG (12); Southey, MC (12); Teo, SH (12); Beckmann, MW (12); Lubinski, J (12); Pharoah, PDP (12); Goode, EL (12); Gronwald, J (12); Karlan, BY (12); Kjaer, SK (12); Kiemeney, LA (12); Ramus, SJ (12); Menon, U (12); Tworoger, SS (12); Rossing, MA (12); Goodman, MT (12); Doherty, JA (12); Moysich, KB (12); Pejovic, T (12); Cook, LS (12); Matsuo, K (11); Wu, AH (11); Jakubowska, A (11); Dork, T (11); Easton, DF (11); Ziogas, A (11); Sellers, TA (11); Lazaro, C. (11); Odunsi, K (11); Wentzensen, N (11); Campbell, I (11); Modugno, F. (11); Heitz, F (11); Jensen, A (11); Hogdall, E (11); Terry, KL (11); Bandera, EV (11); Le, ND (11); Sieh, W (11); show less...

University: Karolinska Institutet (69); Uppsala University (41); Lund University (23); Stockholm University (15); University of Gothenburg (12); Linköping University (8); show more...; Royal Institute of Technology (6); Swedish University of Agricultural Sciences (6); Chalmers University of Technology (5); Umeå University (2); Luleå University of Technology (2); Malmö University (2); Linnaeus University (2); RISE (2); Örebro University (1); Jönköping University (1); Mid Sweden University (1); show less...

Language: English (122)

Research subject (UKÄ/SCB): Natural sciences (39); Medical and Health Sciences (38); Engineering and Technology (7); Agricultural Sciences (3); Social Sciences (3); Humanities (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view